acts in Biological Technology

Sheet of carbon atoms acts like a billiard table, physicists find

RIVERSIDE, Calif. A game of billiards may never get smaller than this. Physicists at UC Riverside have demonstrated that graphene a one-atom thick sheet of carbon atoms arranged in hexagonal rings can act as an atomic-scale billiard table, with electric charges acting as billiard balls. ...

Sheet of carbon atoms acts like a billiard table, physicists find

RIVERSIDE, Calif. A game of billiards may never get smaller than this. Physicists at UC Riverside have demonstrated that graphene a one-atom thick sheet of carbon atoms arranged in hexagonal rings can act as an atomic-scale billiard table, with electric charges acting as billiard balls. ...

Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit

...metic product. Viscontour Serum topical hyaluronic acid offers a simple and convenient way of moisturizing the skin. When applied topically Viscontour acts as a natural moisture reservoir for the skin. "We are excited about the availability of the BenzaClin carekit because it broadens the landscap...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

...e treatment of hepatitis C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C. Safe Harbor Statement Statements in this press release that are not st...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

... ANA773 is the Company's oral inducer of endogenous interferons that acts via the toll like receptor 7 (TLR7) pathway. Phase I Clinical Tria...l of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C. Saf...

Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results

...he treatment of hepatitis C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C. Safe Harbor Statement Statements in this press release that are...

MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients

... proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pr...

Looking Older Than You Are May Have Little to Do With Wrinkles

...cused on the cosmetic applications for restoring facial volume deficiencies caused by age and genetic structure. Sculptra, as a bio-stimulatory agent, acts over time to create self-production of new collagen in the skin. It is the only recognized product to have this effect. In her presentation Dr. Fi...

Muscular protein bond -- strongest yet found in nature

...t is a bond involving titin, a giant among proteins. Titin is considered a molecular "ruler" along which the whole muscle structure is aligned, and it acts as an elastic spring when a muscle is stretched. Titin plays a role in a wide variety of muscle functions, and these in turn hinge on the stability...

SynCo Bio Partners Increases its Capacities by Expanding its Quality Team

...ant proteins in our state-of-the-art, GMP-licensed facilities since inception in 2000. Focused solely on biopharmaceuticals, SynCo Bio Partners acts as a strategic, long-term partner delivering product on time to the highest quality standards. SynCo 's team are committed to exceeding customer expec...

GPhA Calls Senate HELP Committee Action Disappointing for Countless Patients

...t patients can truly access lifesaving biogeneric medicines in a timely manner. "We hope that when the House Energy and Commerce Committee acts it follows the lead of its Chairman in approving a market exclusivity period that puts patients first. History has shown that a balance between innov...

Scientists create first electronic quantum processor

... Physics, the team manufactured two artificial atoms, or qubits ("quantum bits"). While each qubit is actually made up of a billion aluminum atoms, it acts like a single atom that can occupy two different energy states. These states are akin to the "1" and "0" or "on" and "off" states of regular bits empl...

Access Pharmaceuticals CEO Interviewed on Financial Website

...prietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; and Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which has demonstrated both pre-clin...

Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours

...ment that inhibits the protein-protein interaction between Raf-1 (key signalling kinase in the MAP kinase pathway) and Rb (retinoblastoma protein). Rb acts as a barrier to cell division and proliferation. However, when Raf-1 physically interacts with Rb, it triggers a cascade of signals that eventually ov...

Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program

... extensive nationwide distribution network." About HC International, Inc. HC International is a focused and dedicated organization that acts as a premier information resource for institutional investors, hedge funds, buy and sell-side analysts, small to large brokerage firms and accredited ...

Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)

... its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-cl...

Researchers solve 'bloodcurdling' mystery

...he blood clotting protein von Willebrand factor (VWF). By manipulating single molecules of this A2 domain, the researchers found that the A2 domain acts as a highly sensitive force sensor, responding to very weak tensile forces by unfolding, and losing much of its complex three-dimensional organization...

Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598

...e treatment of hepatitis C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C. Safe Harbor Statement Statements in this press release that are not...

PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice

... termed a "retaliatory metabolite" that targets multiple pathways of cellular stress and myocardial injury to counter net ATP catabolism and, as such, acts as a key regulator of cellular energetics. Endogenous adenosine protects cells from multiple pathways of injury such as inflammation, apoptosis and ne...

Ausio Pharmaceuticals to Present at Bio(R) 2009

...of menopausal symptoms and BPH. AUS-131 Preclinical and Phase 1 Clinical Results AUS-131 is pure, synthetic S-equol, a soy metabolite, and acts as a nonsteroidal, nonhormonal, selective estrogen receptor beta (ER beta) agonist. The safety profile of AUS-131 in FDA-required preclinical studies ...

SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award

...ant proteins in our state-of-the-art, GMP-licensed facilities since inception in 2000. Focused solely on biopharmaceuticals, SynCo Bio Partners acts as a strategic, long-term partner delivering your product on time and to the highest quality standards. All our staff are committed to exceeding custo...

Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights

...ll molecule inducer of endogenous interferons that acts via the toll-like receptor 7 (TLR7) pathway. Anad...73, an Oral Inducer of Endogenous Interferons that acts Via TLR7, for the Treatment of HCV." ...73, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also develop...

Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm

... its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumo...

AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting

... with an IC50 value of 10nM and proved to be a potent inhibitor of Akt phosphorylation in cellular assays. Mode-of-action studies showed that AEZS-126 acts as an ATP competitive compound. The in vitro antiproliferative activity against different human tumor cell lines (MDA-MB 468, U87, Hct116, PC-3, A549 ...

Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting

... its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumo...

Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs

...ion and treatment of dysmenorrhoea, a condition characterized by abnormal contractions of the uterus during menstruation causing severe pain. VA111913 acts by blocking vasopressin 1a receptors in smooth muscle in the uterus wall, which in response to elevated vasopressin levels leads to dysmenorrhoea. VA1...

Bridging the gap in nanoantennas

...television broadcasting, point-to-point radio communication, wireless LAN, radar, and space exploration. In turn, an optical antenna is a device which acts as an effective receiver and transmitter of visible or infrared light. It has the ability to concentrate (focus) light to tiny spots of nanometer-scal...

Ancient diatoms lead to new technology for solar energy

...late. A biological agent is then used to precipitate soluble titanium into very tiny "nanoparticles" of titanium dioxide, creating a thin film that acts as the semiconductor for the dye-sensitized solar cell device. Steps that had been difficult to accomplish with conventional methods have been made ea...

Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results

...eloping two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also developing ANA773 for the treatment of cancer. Safe Harbor Statement Statements in this...

Physicists discover important step for making light crystals

...DARPA challenge. The new method cools the atoms in an optical lattice by literally squeezing the heat out of them and into a surrounding BEC, which acts as a heat sink. Ho has already shared the cooling method with the three teams in recent DARPA Meetings. The teams are led by the Massachusetts Inst...

Siemens Offers Life Science Solutions Design Guide for Consulting Engineers

...eed to closely examine their building systems and integrate solutions that will help them in these areas," said Feliciano-Welpe. "Our new design guide acts as a catalyst for the success of these efforts and will assist them in the process." As a leading provider of energy and environmental solutions...

Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier

...arketing of Kutai to help generate increased sales revenues," said Sinobiopharma Vice President, Xuejun Chen. About Kingchem LLC Kingchem LLC acts as a third party manufacturer's agent, representing a group of first class manufacturers in China and in other parts of the world in the pharmaceutica...

Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry

...eloping two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also developing ANA773 for the treatment of cancer. Safe Harbor Statement Statements in this pr...

ThromboGenics Announces Business Update and 2008 Full Year Results

... as double digit royalties on the same basis. TB-403 is being developed as an anti-cancer agent, and is currently in a Phase Ib clinical trial. TB-403 acts selectively by inhibiting the growth of new blood vessels in cancer tissue but not in normal tissue. Financial Highlights - In 2008, Throm...

GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act'

...s available to consumers. And we look forward to the bipartisan introduction of a companion bill in the Senate in the near future. "As our nation acts to strengthen our health care system, our priority must be to reduce costs while increasing access to quality care. Studies continue to show that cre...

Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

...s dual 5HT2A receptor antagonist/dopamine receptor phosphoprotein modulator (DPPM) for the treatment of schizophrenia. ITI-007 has dual properties; it acts as a post-synaptic antagonist and as a pre-synaptic partial agonist. The combination of ITI-007's high-potency blockade of 5HT2A receptors and unique...

Bristly spheres as capsules

...ch other. Aggregation then continues until the resulting ensemble of cores is, as a whole, surrounded by a sufficiently dense layer of bristles, which acts as a shield toward additional particles. Cores with an even smaller number of polymer bristles aggregate into extended curved layers that close the...

Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures

... it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), REVIVE acts as a tissue scaffold facilitating rapid tissue ingrowth and can be utilized in a variety of soft tissue repair procedures, including the repair of ing...

DNA 11, Creators of DNA Art, Opens First Pop-up Gallery

...w blocks from the Pacific Ocean and was constructed using the most innovative green technologies and materials available. The home's design aesthetic acts as the perfect setting to display the modern look of the various DNA 11 artwork . To book an appointment at the DNA 11 House, please send an e-ma...

New Genomatica Chemical Process Targets Ailing Ethanol Assets

...ounds per year, and the market is broadly valued at $2 billion per year. MEK is a solvent used in coatings and paint, also known as butanone. MEK also acts as a processing tool for synthetic rubber and polyester resin products. Because it is expected to be cost-advantaged against traditional manufa...